Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 6

1.

Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.

Mansi R, Wang X, Forrer F, Waser B, Cescato R, Graham K, Borkowski S, Reubi JC, Maecke HR.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):97-107. doi: 10.1007/s00259-010-1596-9. Epub 2010 Aug 18.

PMID:
20717822
2.

Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.

Mansi R, Wang X, Forrer F, Kneifel S, Tamma ML, Waser B, Cescato R, Reubi JC, Maecke HR.

Clin Cancer Res. 2009 Aug 15;15(16):5240-9. doi: 10.1158/1078-0432.CCR-08-3145. Epub 2009 Aug 11.

3.

Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states.

Gonzalez N, Moody TW, Igarashi H, Ito T, Jensen RT.

Curr Opin Endocrinol Diabetes Obes. 2008 Feb;15(1):58-64. doi: 10.1097/MED.0b013e3282f3709b. Review.

4.

Syntheses and biological activities of potent bombesin receptor antagonists.

Llinares M, Devin C, Chaloin O, Azay J, Noel-Artis AM, Bernad N, Fehrentz JA, Martinez J.

J Pept Res. 1999 Mar;53(3):275-83.

PMID:
10231715
5.

Expression and characterization of cloned human bombesin receptors.

Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT.

Mol Pharmacol. 1995 Jan;47(1):10-20.

PMID:
7838118
6.

Bombesin stimulates growth of human gastrinoma.

Chung DH, Evers BM, Beauchamp RD, Upp JR Jr, Rajaraman S, Townsend CM Jr, Thompson JC.

Surgery. 1992 Dec;112(6):1059-65.

PMID:
1455308

Supplemental Content

Support Center